In vitro studies of poison oak immunity. I. In vitro reaction of human lymphocytes to urushiol
- PMID: 315414
- PMCID: PMC371293
- DOI: 10.1172/JCI109602
In vitro studies of poison oak immunity. I. In vitro reaction of human lymphocytes to urushiol
Abstract
Poison oak, ivy, and sumac dermatitis is a T-cell-mediated reaction against urushiol, the oil found in the leaf of the plants. This hapten is extremely lipophilic and concentrates in cell membranes. A blastogenesis assay employing peripheral blood lymphocytes obtained from humans sensitized to urushiol is described. The reactivity appears 1--3 wk after exposure and persists from 6 wk to 2 mon. The dose-response range is narrow, with inhibition occurring at higher antigen concentrations. Urushiol introduced into the in vitro culture on autologous lymphocytes, erythrocytes and heterologous erythrocytes produces equal results as measured by the optimal urushiol dose, the intensity of reaction, and the frequency of positive reactors. This suggests that the urushiol is passed from introducer to some other presenter cell. Although the blastogenically reactive cell is a T cell, there is also a requirement for an accessory cell, found in the non-T-cell population, for reactivity. Evidence is presented that this cell is a macrophage.
Similar articles
-
In vitro studies of poison oak immunity. II. Effect of urushiol analogues on the human in vitro response.J Clin Invest. 1979 Nov;64(5):1449-56. doi: 10.1172/JCI109603. J Clin Invest. 1979. PMID: 315415 Free PMC article.
-
Processing of urushiol (poison ivy) hapten by both endogenous and exogenous pathways for presentation to T cells in vitro.J Clin Invest. 1994 May;93(5):2039-47. doi: 10.1172/JCI117198. J Clin Invest. 1994. PMID: 7910172 Free PMC article.
-
Enrichment and function of urushiol (poison ivy)-specific T lymphocytes in lesions of allergic contact dermatitis to urushiol.J Immunol. 1990 Dec 1;145(11):3706-13. J Immunol. 1990. PMID: 2147199
-
The use of human T-lymphocyte clones to study T-cell function in allergic contact dermatitis to urushiol.J Invest Dermatol. 1990 Jun;94(6 Suppl):108S-111S. doi: 10.1111/1523-1747.ep12876061. J Invest Dermatol. 1990. PMID: 1693644 Review.
-
Recent developments in the pathogenesis of allergic contact dermatitis.Arch Dermatol. 1991 Oct;127(10):1558-63. Arch Dermatol. 1991. PMID: 1929465 Review.
Cited by
-
Lymphocyte transformation to membrane-conjugated, liposome-conjugated, or unconjugated pentadecylcatechol in the guinea pig.Arch Dermatol Res. 1985;277(3):209-13. doi: 10.1007/BF00404318. Arch Dermatol Res. 1985. PMID: 4015184
-
In vitro studies of poison oak immunity. II. Effect of urushiol analogues on the human in vitro response.J Clin Invest. 1979 Nov;64(5):1449-56. doi: 10.1172/JCI109603. J Clin Invest. 1979. PMID: 315415 Free PMC article.
-
Urushiol (poison ivy)-triggered suppressor T cell clone generated from peripheral blood.J Clin Invest. 1988 Sep;82(3):825-32. doi: 10.1172/JCI113685. J Clin Invest. 1988. PMID: 2458387 Free PMC article.
-
Processing of urushiol (poison ivy) hapten by both endogenous and exogenous pathways for presentation to T cells in vitro.J Clin Invest. 1994 May;93(5):2039-47. doi: 10.1172/JCI117198. J Clin Invest. 1994. PMID: 7910172 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources